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1. Introduction
  Since the first case of healthy test-tube baby was born in 
1992, a growing number of test-tube baby has become an 
ideal way to solve some family's childbearing problem[1]. 
The success rate of intracytoplasmic sperm injection (ICSI) 
treatment is still is not ideal, so how to improve it has 
become the main directions for researchers. Studies have 
shown that sperm-zona pellucida (ZP) plays an important 
role in the normal process of fertilization. According to the 
changes of ZP birefringence, ZP birefringence曒0.5 is high 
zona birefringence (HZB); ZP birefringence <0.5 is low zona 
birefringence (LZB)[2]. So if the ICSI is carried out according 
to different zona pellucida birefringence, it is still a problem 
whether there is different quality of fertilized embryos 
and different pregnancy rate. This study was designed to 
investigate whether ZP can affect pregnancy outcomes.
2. Materials and methods
2.1. Material and groups
  The launching of this subject has been approved by the 
medical ethics committee of the First Affiliated Hospital 
of Sun Yat-sen University. A total of 46 infertile patients 
who received ICSI from October 2007 to September 2008 
in our hospital were taken as the research object. The 
Objective: To explore the effects of different M栻 stage oocytes zona pellucida birefringence on 
pregnancy outcome. Methods: A total of 46 couples with infertile which induced by single cause 
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into the high zona birefringence (HZB)/HZB group, HZB/low zona birefringence (LZB) group and 
LZB/LZB group according to different oocytes zona pellucida birefringence. Intracytoplasmic 
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LZB group>LZB/LZB group) (P<0.05). But there was no significantly different between the number 
of oocytes and fertilization rate of these groups (P>0.05). Logistic regression analysis showed 
that factors affect M栻 stage oocytes zona pellucida birefringence were age, basal FSH level and 
the LH level on the day of HCG injection. Age and FSH levels were negatively correlated with 
the single oocyte zona pellucida birefringence; While the LH level on the day of hCG injection 
was positively correlated with the single oocyte zona pellucida birefringence. Conclusions: The 
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LH level on the day of hCG injection. The birefringence value of zona pellucida can affect the 
pregnancy outcome.
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inclusion criterions were as follows: Male factor is the only 
reason for infertility; Scheduled for ICSI treatment; 5曑
oocyte number<30. Patients aged <35 and with 2 transferred 
embryos were included in the study. They were randomly 
divided into the HZB/HZB group (n=20), HZB/LZB group 
(n=16) and LZB/LZB group (n=10) according to different 
oocytes zona pellucida birefringence of embryos transferred 
before fertilization.
 
2.2. Agents and method
2.2.1. Main reagents and instruments
  Human serum albumin (HSA): Sweden Vitrolife company; 
Gonal-F injection: recombinant follicle-stimulating 
hormone (r-FSH), Swiss Serono Company, 75 IU per ramus; 
Human menopausal gonadotropin (HMG): Lizhu company, 
75 IU per ramus. Profasi injection: human chorionic 
gonadotropin (hCG), Swiss Serono Company, 5 ramus; 
Triptorelin (GnRH-a) and injection: triptorelin acetate 
purchased from Beaufour-Ipsen International,France (3.75 
mg/ramus). Hyaluronidase: Sigma Company. Polarization 
microscope (Polscope): OCTAX ICSI Guard TM polarized light 
system and OCTAX EyeWare TM measuring software (CRI 
Company, USA); Olympus 桖 71 inverted microscope (Type 
桖 70, Japan; with the Hoffman system, Germany); Incubator: 
French FIV6; CO2 incubator: American Forma,type 371 3308; 
Super-clean worktable: Denmark K-SYSTEMS, type in-vitro 
fertilization (IVF)-L26; Sperm counting chambers: Israel 
Makler Counter chamber, 0.01 mm2, 10 毺m deep; Pasteur 
pipettes: Sigma Company (S6143), after disinfection.
2.2.2. Experimental method
  After 3-7 days abstinence, spermatozoa were fetched 
by masturbation in the relatively sterile conditions. After 
routine analysis, semen 1.5-5 mL was placed between 
80% lower phase solution and 40% upper phase liquid 1.5 
mL after 30 min incubation. It was centrifuged at 200 g 暳
18 for 20 min, supernatant was removed. And it was added 
into 2 mL G-FERT medium, well mixed before centrifuge 
washing (200 g暳5 min). Then supernatant were abandoned, 
the precipitate was break and mixed well then added into 
the bottom of the 0.4-0.6 mL Falcon tube with G-FERT 
culture solution which containing 5% HSA. The bottle cap 
was opened and placed in a 6% CO2 incubator to hatch and 
prepare for fertilization.
  Oocyte transvaginal was obtained under B ultrasound 
guidance by superovulation. The collected follicular fluid was 
poured into a 60 mm petri dish, and the selected eggs were 
washed in the culture medium containing 5% HAS G-MOPS. 
OCCC were inhaled into the buffered HTF (G-MOPS) solution 
Petri dishes (Nunc 35 mm) which contained hyaluronidase 
(80 IU/mL) and repeated pipetting. The eggs were transferred 
to a Petri dish with culture solution containing 5% HSA 
G-MOPS and then washed. OCTAX ICSI Guard TM imaging 
system was used to observe the zona pellucida. Then them 
were transferred into prepared Falcon1006 petri dishes 
according to different groups and received ICSI.
After 16-18 h of ICSI fertilization, morphology and number of 
the fertilized egg prokaryotic was checked under an inverted 
microscope. Two pronuclei and two polar bodies within 
the egg under the inverted microscope marked the normal 
fertilization. After 72 h of ovum retrieval, the high-quality 
embryos for artificial insemination was choosed under 
B-guided .
2.3. Results determination 
2.3.1. Pregnancy and follow-up
  After 14 d of ET, urine and serum 毬-hCG level were 
measured to determine whether there is biochemical 
pregnancy, if positive, continue to give the corpus luteum 
support. 28 days after ET, B ultrasound was adopted to detect 
the fetal heart rate, fetal sac and embryo development, 
diagnosed clinical pregnancy.
2.3.2. General information
  The patient’s general information (age, height, weight, 
etiology, etc.) was collected, the dose of GnRH-a down-
regulated, basis, hormone level (FSH, LH, E2, prolactin, 
testosterone) on the start date and the day of HCG injection, 
Gn dosage and the time for usage, endometrial thickness, 
the number of oocytes, M栻 stage oocytes number, fertilized 
egg score in pronuclear stage, D3 embryo score, the number 
of top quality embryos, fertilization rate, cleavage rate, 
implantation rate, pregnancy rate were measured. Formula 
of various rates was as following:
Fertilization rate = fertilized egg number/M栻 oocytes暳 
100%;
Implantation rate = total number of the plant embryo/total 
number of transplanted embryonic暳100%;
Clinical pregnancy rate = number of pregnancy cycles/
number of transfer cycles 暳100%.
  
2.4. Statistical methods
  Data were expressed as mean暲SD values, the enumeration 
data were expressed as frequency and percentage. One 
sample t-Test was applied in the comparison between two 
groups. Mean comparison in groups was conducted with 
single factor variance analysis. Correlation and regression 
analysis were identified by logistic regression, single factor 
regression analysis was performed to analyze the impact 
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of independent variables to the dependent variables, the 
independent variables which P<0.05 were included in 
multiple regression analysis. All of the data were analyzed 
by SPSS16.0 statistics software, P<0.05 was regarded as 
statistical significance.
3. Results
3.1. Effect of oocyte zona pellucida birefringence on clinical 
pregnancy outcome
  The average age of cases was (30.00暲2.25) years old, and 
the average period was 1.10暲0.31; the retrieved oocyte 
number was 559, and the average number of oocytes 
retrieved per cycle was 12.15暲3.27.
3.2. Comparison of clinical pregnancy outcome
  The result showed signficant differences in he proportion 
of HZB oocytes, the implantation rate and the pregnancy rate 
among the groups .From the HZB/HZB group to the LZB/LZB 
group, all of the above indicators showed a decreasing trend. 
But the retrieved oocyte number and the fertilization rate had 
no significant difference among groups, which suggested that 
the higher oocyte zona pellucida birefringence, the better 
clinical pregnancy outcome would be. In addition, during 
the 46 cycles, the number of top quality embryos obtained 
after fertilization of all HZB oocytes was significantly higher 
than the LZB oocytes (43.17% vs .22.81%, P <0.05) (Table 1).
Table 1
Comparison of the general situation, hormone levels, situation of 










11.58暲4.94 12.33暲2.82 11.67暲3.87 0.332 
HZB oocytes 
proportion (%)
45.08 30.20   17.35 0.002 
Fertilization rate (%) 82.92 79.87   80.61 0.757 
Implantation rate (%)  40.00 25.00   10.00 0.046 
Pregnancy rate (%) 65.00 37.50 110.00 0.013 
Table 2
Factors affecting the M栻 stage oocytes zona pellucida birefringence (single factor analysis).
Parameters   B SE Wald Sig. Exp(B)
95% CI for EXP(B)
Lower Upper
Age (years old) -0.071 0.025 8.073 0.004 0.931 0.887 0.978
BMI (kg/m2)   0.013 0.041 0.095 0.758 1.013 0.935 1.097
cycle (n)   0.282 0.213 1.746 0.186 1.326 0.873 2.014
GnRH-a dose (mg)   0.650 0.783 0.690 0.406 1.916 0.413 8.882
Basic hormone levels FSH (IU/L) -0.138 0.060 5.329 0.021 0.871 0.775 0.979
LH (IU/L) -0.070 0.046 2.271 0.132 0.932 0.851 1.021
FSH/LH   0.092 0.065 2.005 0.157 1.097 0.965 1.246
E2 (pg/mL) -0.004 0.005 0.765 0.382 0.996 0.987 1.005
Testosterone -0.105 0.389 0.072 0.788 0.901 0.420 1.931
PRL   0.027 0.010 7.646 0.056 1.027 1.008 1.047
Hormone levels on the start-up day FSH (IU/L) -0.051 0.128 0.163 0.686 0.950 0.740 1.220
LH (IU/L) -0.092 0.150 0.376 0.540 0.912 0.680 1.224
E2 (pg/mL) -0.011 0.006 3.112 0.078 0.989 0.976 1.001
Gn application time (d) -0.239 0.064 14.040 0.000 0.787 0.695 0.892
Gn dose (ramus) -.022 0.009 6.172 0.013 0.979 0.962 0.995
Hormone levels on the day of hCG injection LH (IU/L)   0.437 0.187 5.448 0.020 1.548 1.073 2.234
E2 (pg/mL)   0.000 0.000 13.766 0.000 1.000 1.000 1.000
Progestin -0.637 0.200 10.117 0.001 0.529 0.357 0.783
Retrieved oocyte number (n)   0.021 0.019 1.243 0.265 1.022 0.984 1.061
M栻stage oocytes number (n) -0.019 0.023 0.713 0.398 0.981 0.939 1.025
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3.3. Factors affecting M栻 stage oocytes zona pellucida 
birefringen
   The results were shown that age, basal FSH level, hormone 
application time and dose, the LH level and P level on the 
day of hCG injection all affected the single oocyte zona 
pellucida birefringence (Table 2). The independent variable 
with P<0.05 in single factor analysis were included in the 
multivariate regression analysis. The result shown that age, 
basal FSH level, the LH level on the day of hCG were still 
the factors which affect edthe single oocytes zona pellucida 
birefringence (Table 3).
Table 3
Factors affecting the M栻 stage oocytes zona pellucida birefringence ( 
multivariate analysis).
Parameters   B SE Wald Sig. Exp(B) 95% CI for EXP(B)
Lower Upper
Age (years old) -0.066 0.027   5.753 0.016 0.936 0.887 0.988
Basic FSH (IU/L) -0.235 0.066 12.863 0.000 0.790 0.695 0.899
HCG day LH 
(IU/L)
  0.619 0.207   8.946 0.003 1.857 1.238 2.785
4. Discussion
  Oocytes zona pellucida birefringence is an important 
indicator to assess oocyte quality, it also reflect the complex 
structure and integrity of the zona. However, this has 
not yet been fully confirmed, and there were even some 
controversy. This study found that embryo developed from 
egg with high zona pellucida birefringence may obtain 
better clinical pregnancy outcome, the implantation rate and 
pregnancy rate were significantly higher than the egg with 
low birefringence. That suggested oocyte zona pellucida 
birefringence had good prediction of clinical pregnancy 
prognosis, which is consistent with the related studies[3]. 
In addition, this study found that there was no statistical 
difference between the fertilization rate of the egg with 
high zona pellucida birefringence and the egg with low 
birefringence, which maybe related to the ICSI treatment, 
but has nothing to do with the natural fertilization. And the 
number of top quality embryos obtained after fertilization 
of all HZB oocytes was significantly higher than the LZB 
oocytes, which suggested that eggs with higher birefringence 
has better egg quality and embryo development[4,5].
  A number of studies have confirmed the success rate of 
in vitro fertilization-embryo transfer is directly related to 
the quality of transferred embryos. While the IVF center 
at home and abroad both evaluate the embryo quality 
based on the embryo morphology score, but its limitations 
can’t be ignored[6,7]. So find a reliable and stable detection 
indicators can not only assess egg quality and predict the 
developmental potential of embryos accurately, but also 
help to improve the clinical pregnancy outcome. OCTAX 
ICSI Guard TM system is a device which can automatically 
detect and analyze the molecular structure within the egg 
by the polarized light principle, it can record and analyze 
the zona pellucida data quickly and efficiently, and doesn’t 
need more than one angle measurement and additional 
calculation[8,9]. Moreover, this study determined that using 
polarized light to measure photoresist strength of zona 
pellucida and then to predict the oocyte quality and the 
vitality after fertilization is more accurate. Combined with 
some foreign studies, this study suggest that zona pellucida 
birefringence may be a reliable and stable indicator that 
can predict the potential of the egg and the development of 
embryos, and reduce the number of transferred embryos, 
and thus can avoid the occurrence of multiple pregnancies. 
During the study process, we found that this method does 
not damage the eggs nor affect its activity[10].
  The study found that the patient’s age, basal FSH levels, the 
LH level on the day of hCG injection can be  independent 
factor that influencing the single oocyte zona pellucida 
birefringence. There was a significant negative correlation 
between the patient’s age, basal FSH levels and the single 
oocyte zona pellucida birefringence; while the LH level on 
the day of hCG injection had a positive correlation with it. 
The main reason we consider is that with the increasing 
of the age, the pregnancy rate decreased, the number 
of follicles in the ovary and the number of oocytes were 
significantly reduced, so was the quality of the dominant 
follicle. The age with the most reproductive potential is 18-
25, it began to decline since 30, and after 35 the ovarian 
follicles storage decreased significantly[11]. We also think 
that there was a negative correlation between the patient’s 
age and oocytes zona pellucida birefringence. The elder the 
patient is, the lower the zona pellucida birefringence will 
be. The oxygen free radicals in the follicle increased with 
the age, which made the egg apoptosis increased, thereby 
further reduce the pregnancy rate. Some studies suggest 
that basal FSH levels is often considered to be a trend of 
reducing the follicles and  indicators of reducing ovarian 
reserve function, which led to the decreased quality of 
oocytes and not ideal clinical pregnancy outcome. However, 
this conclusion is still controversial[12].
  Some studies think that there are estrogen receptors in 
human oocyte. By paracrine and autocrine-estrogen involved 
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in the development and maturation process of the follicle 
and oocyte, therefore excessively low LH levels may lead 
to the follicle developmental disorders and immature eggs. 
The oocyte zona pellucida birefringence increases with the 
increase of LH levels, which indicating better quality of the 
egg. Therefore in order to obtain better clinical pregnancy 
outcome, it is very important to reduce the the GnRHa dose 
or increase the LH dose or maintain an appropriate level of 
LH of HMG, prevent them from being too high or too low[13].
  In summary, this study found oocytes zona pellucida 
birefringence and clinical pregnancy outcome was positively 
correlated by analyzing the zona pellucida birefringence of 
patients with ICSI and the clinical pregnancy outcomes and 
the related factors. Using high birefringence zona eggs can 
obtain better pregnancy outcomes, which suggested oocyte 
zona pellucida birefringence is a reliable indicator to predict 
the developmental potential of the egg and embryonic. This 
study also found that the patient’s age, basal FSH levels, the 
LH level on the day of hCG injection can affect the oocyte 
zona pellucida birefringence to different degree, thereby 
affecting the quality of the egg. Therefore take positive 
measures to control the controllable factors to improve 
egg quality will improve the patient’s clinical pregnancy 
outcomes, and then improve the implantation rate and 
pregnancy rate.
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